Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Ruconest for Treatment of Hereditary Angioedema (HAE)

Drug Name

Ruconest

Company / Licensee

Pharming Group and Salix Phamaceuticals

Product Description

Human recombinant C1-esterase inhibitor

Current Indication

Hereditary angioedema (HAE)

Market Sector

Haematology

Development Status

Approved in the US and Europe
Expand
Close
Close
Close

Go Top